LMDX LumiraDx Limited

LumiraDx Ltd provides technical testing and analysis solutions. LumiraDx Ltd was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. The company was incorporated in 2002 and is based in London, Greater London, United Kingdom.

$9.87  +0.21 (2.17%)
As of 12/03/2021 15:41:26 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  United Kingdom
Country of incorporation:  
IPO date:  03/19/2021
Outstanding shares:  45,028,547
Average volume:  124,494
Market cap:   $434,975,764
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   19.64
PB ratio:   7.16
PS ratio:   1.61
Return on equity:   12.10%
Net income %:   18.19%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy